Grupo Vithas, the Healthcare group headed by the Gallardo family and Criteria Caixa bank, has hit trouble in their attempts to buy Valencia based Grupo Hospitales Nisa and its seven healthcare centers throughout Valencia, Madrid and Andalucía provinces. Vithas, based in Madrid and with Catalan backing, has said it intends to complete the takeover in order to widen their network, becoming Spain’s second largest private hospital group.
While Vithas has managed to secure purchasing options from some of Nisa’s major shareholders (totalling around 30% of shares), the company has also met serious resistance from well-organized minority shareholders, who have launched a share-merger process in order to present a united front and “a position of strength.” Together, the resisting shareholders represent over 53% of NIsa’s active shares.
A number of these shareholders have considered Vithas’ move to be a hostile takeover, having rejected their offers and the extended two-year payment plan. As a result, Vithas decided not to press ahead with the initial round of purchases, whose options were to expire in late June.
Full Content: El Confidencial/a>
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Subscribers Defend $4.7 Billion Antitrust Verdict Against NFL in Court Filings
Jul 19, 2024 by
CPI
Von der Leyen Calls for Competition Policy to Boost EU Companies’ Growth
Jul 19, 2024 by
CPI
Vermont AG Sues Pharmacy Benefit Managers Over Drug Prices
Jul 18, 2024 by
CPI
Australians Face Increased Stamp Prices Following ACCC Approval
Jul 18, 2024 by
CPI
Live Nation Seeks Dismissal of DOJ Antitrust Allegations
Jul 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI